Klingenstein Fields & Co
TEVA icon

Klingenstein Fields & Co’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Klingenstein Fields & Co’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-28,120
Closed -$934K – 224
2017
Q2 		$934K Hold
28,120
– – 0.04% 132
2017
Q1 		$902K Sell
28,120
-7,191
-20% -$245K 0.04% 133
2016
Q4 		$1.28M Sell
35,311
-69,643
-66% -$2.78M 0.06% 120
2016
Q3 		$4.83M Sell
104,954
-87,893
-46% -$4.59M 0.22% 70
2016
Q2 		$9.7M Buy
192,847
+38,322
+25% +$2.04M 0.45% 55
2016
Q1 		$8.27M Buy
154,525
+149,145
+2,772% +$8.75M 0.41% 57
2015
Q4 		$353K Hold
5,380
– – 0.02% 169
2015
Q3 		$304K Hold
5,380
– – 0.02% 179
2015
Q2 		$318K Hold
5,380
– – 0.01% 193
2015
Q1 		$335K Hold
5,380
– – 0.01% 191
2014
Q4 		$309K Sell
5,380
-60
-1% -$3.34K 0.01% 197
2014
Q3 		$292K Sell
5,440
-800
-13% -$42.4K 0.01% 203
2014
Q2 		$327K Buy
6,240
+140
+2% +$7.16K 0.01% 202
2014
Q1 		$322K Sell
6,100
-1,100
-15% -$50.8K 0.01% 205
2013
Q4 		$289K Hold
7,200
– – 0.01% 263
2013
Q3 		$272K Sell
7,200
-1,500
-17% -$58.5K 0.01% 262
2013
Q2 		$341K Buy
+8,700
New +$339K 0.01% 248

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Highfields Capital Management
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Klingenstein Fields & Co's TEVA Position: Q3 2017 in Review

Klingenstein Fields & Co sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 28,120 shares — an estimated $934K sold.

Klingenstein Fields & Co first reported a position in TEVA in Q2 2013 and held it in 17 quarters. The position peaked at $9.7M in Q2 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Klingenstein Fields & Co reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
  • Klingenstein Fields & Co sold 28,120 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $934K.
  • Klingenstein Fields & Co first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 17 quarters.
  • Klingenstein Fields & Co's Teva Pharmaceutical Industries Limited position peaked at $9.7M in Q2 2016.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Klingenstein Fields & Co's 13F filing for Q3 2017, filed 1 Nov 2017.